Allergen avoidance works

3rAirsonett is an evidence-based, non-pharmaceutical treatment for atopic asthma. The treatment is non-invasive and has an excellent safety record.

Airsonett is based on TLA (Temperature controlled Laminar Airflow) technology, which stops body convection and creates an area of essentially allergen free air in the patient’s breathing zone.

Airsonett is based on TLA (Temperature controlled Laminar Airflow) technology, which stops body convection and creates an area of essentially allergen free air in the patient’s breathing zone.  Airsonett drastically reduces the level of allergens inhaled during night-time sleep and gives the asthmatic’s hyperactive immune system long and regular periods of essential recovery.

Allergen avoidance

In the case of atopic asthma, the immune system’s abnormal reaction to inhaled allergens is an important contributory factor in both acute and chronic asthma symptoms. Minimising inhaled allergens such as those from mites, cats and dogs is a first step towards improving the control of perennial atopic asthma.

High altitude studies of children who are allergic to mites indicate that if the patient can avoid allergens for a long period of time (allergy avoidance) airway inflammation is reduced and, as a result, symptoms improve and the sensitivity to allergens is reduced. These studies indicate that a significant reduction in exposure to inhalant allergens can be an effective way of treating atopic asthma.

Measures that effectively reduce exposure to allergens indoors at night are therefore a new and valuable way of reducing the symptoms of asthma for patients who suffer from perennial atopic asthma. Studies of air purifiers and other ventilation measures, on the other hand, have shown no significant effect on patients with perennial atopic asthma, which indicates that the reduction in allergen exposure has not been sufficiently comprehensive to affect the airway inflammation.

Airsonett proves that allergen avoidance works.